H.R.153: Protecting Consumer Access to Generic Drugs Act of 2021

About This Bill

Bill Version

Bill Summary

Protecting Consumer Access to Generic Drugs Act of 2021 This bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product. Specifically, such an agreement shall, with some exceptions, be a violation of the bill if the filer of a subsequent application to market a drug or biological...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with H.R.153.

Bill Actions

Date Description
March 4, 2021
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Feb. 2, 2021
Referred to the Subcommittee on Health.
Jan. 4, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan. 4, 2021

Introduced in the House by Bobby L. Rush (D-Ill.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page